Recent Updates
Recently added Catalysts
QDEL Neutral Sentiment

QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026

Key Takeaway: QuidelOrtho Corporation will release its financial results for Q3 2026 on November 3, 2026, after market close. A conference call and webcast will follow to discuss these results. The event will be accessible via the company's Investor Relations page. QuidelOrtho focuses on advancing diagnostic solutions for improved patient outcomes.
Price reaction · baseline $12.76 (2026-10-19 close) · hit after-hours · clean, no other QDEL news in the window
day 0 close · peak
+11.4%
day 1
+10.3%
day 3
+7.6%

Market Sentiment Analysis

Full Press Release Details

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of diagnostic solutions, announced today that it will issue a press release to report its financial results for the third quarter 2026 ended September 27, 2026, shortly after the market closes at 4:00 p.m. ET on Tuesday, November 3, 2026.
Following the release, QuidelOrtho will hold a conference call and webcast beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the live webcast on the "Investor Relations" page of the Company's website at https://ir.quidelortho.com/events-and-presentations. A replay of the webcast will be available shortly after the event on the Company's website.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Frequently Asked Questions

When will QuidelOrtho report its Q3 2026 results?

QuidelOrtho will report its Q3 2026 results on November 3, 2026.

What time is the Q3 2026 earnings call?

The earnings call will start at 2:00 p.m. PT / 5:00 p.m. ET.

How can I access the earnings call webcast?

The webcast can be accessed on the Investor Relations page of QuidelOrtho's website.

What is QuidelOrtho's focus?

QuidelOrtho is focused on advancing diagnostic solutions for better patient outcomes.

Last updated: Oct 20, 2026